NASDAQ: CRSP · Biotechnology
Over the past week, CRISPR Therapeutics (CRSP) racked up about 34 mentions across Reddit, X and news plus 73 Polymarket trades, and the read is an Adanos Hold. The crowd averages 51% bullish but is deeply split: Polymarket runs 100% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 15 of 25 analysts rating CRSP a buy.
There is little buzz around CRSP this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 60% buy share sits next to a crowd that ranges from Reddit at 0% to Polymarket at 100%. No other tracker puts the two side by side.
Across 25 analysts the consensus is a Strong Buy: 15 buy calls against 0 sell, with an average 12-month price target of $86.21.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits right on the neutral line, momentum is improving and the 4 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 9 points above the crowd average of 51%, the professionals are more constructive than retail. The split is inside the crowd: Polymarket reads 100% bullish while Reddit sits at 0%, a 100-point spread that single-source trackers miss.
Over the 30-day window, CRISPR Therapeutics (CRSP) buzz held subdued around 30.5 while the price drifted down 17.4% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.7M shares. Updated Jul 27, 2026. Over the last 7 trading days, CRSP lost 4.2%. Buzz activity in the recent week averaged 29.7 and was relatively stable, swinging between 24.6 and 37.3. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 15 of the 19 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Buzz, bullish share, the loudest item and the positive / neutral / negative split for every tracked source over the last 7 days.
Query sentiment for CRSP and 1000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live CRSP sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Jul 27, 2026.
Based on aggregated sentiment from Reddit, X, News and Polymarket sources, CRISPR Therapeutics (CRSP) currently carries an Adanos hold signal with 67/100 conviction. The current cross-source average reads 51% bullish across 4 active sources. Those sources contribute 107 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around CRISPR Therapeutics (CRSP) is fairly quiet with 6 mentions across 17 tracked subreddits. The tone is 0% bullish with falling 3-day activity momentum, suggesting cooling attention.
The crowd reads split on CRISPR Therapeutics (CRSP), averaging 51% bullish across 4 tracked sources over the last 7 days. The two ends of the range are Polymarket at 100% bullish and Reddit at 0%, a 100-point spread. On the professional side, 15 of 25 analysts rate CRSP a buy.
Of the 25 analysts covering CRISPR Therapeutics (CRSP), 15 rate it a buy, 10 a hold and 0 a sell, for a strong buy consensus. The average price target is $86.21. That puts the street ahead of the crowd, which averages 51% bullish.
CRISPR Therapeutics (CRSP) sentiment is mixed across all 4 tracked sources. X reads 36% bullish, News reads 67% bullish, Polymarket reads 100% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad mixed pressure with 67/100 conviction.
Social sentiment data shows consistently mixed discussion around CRISPR Therapeutics (CRSP). All 4 tracked sources lean in different directions, with reddit being the most bearish at 0% bullish. 3-day activity momentum is falling on Reddit, while x and news and polymarket activity is rising. The hold signal carries 67/100 conviction.
Polymarket is the dominant discussion channel with 73 mentions (68% of total volume). X contributes 25 mentions and Reddit contributes 6 mentions and News contributes 3 mentions. Sentiment is mixed across all sources, while x and news and polymarket show rising 3-day activity.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. CRSP's hold signal at 67/100 conviction reflects consistently mixed sentiment across 4 tracked sources. It is a research shortcut, not financial advice.
The CRSP sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
These stocks share a comparable sentiment profile to CRISPR Therapeutics with similar bullish ratios, signal direction and discussion volume. All 6 peers carry hold signals, pointing to broad mixed pressure rather than an CRSP-specific issue.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key